Eric Mortensen, M.D., Ph.D. currently serves as the Vice President & Therapeutic Area Clinical Head for Inflammation and Immunology within Pfizer's Global Innovative Pharma Business. Eric is also the Clinical Inflammation Development Strategy Lead and co-chair for the Therapeutic Area Strategy Team (TAST) within Inflammation to ensure an integrated approach to the development of medicines across the different indications within Inflammation and Immunology.
Eric received his M.D. from the Harvard University and Massachusetts Institute of Technology Division of Health Sciences and Technology and a Ph.D. in biophysics at the Harvard Graduate School of Arts and Sciences. Following a residency in Internal Medicine at Massachusetts General Hospital he completed a fellowship in Gastroenterology at the University of Michigan Medical Center, Ann Arbor.